UTHSC study aims to develop a new way to treat ischemic stroke

Every year, with­out fail, the End­points 11 proves to be the most chal­leng­ing project I face — and def­i­nite­ly re­mains the most fun. In an

Share this article The new alliance will offer end-to-end drug manufacturing solutions for biopharmaceutical companies. Credit: IM Imagery / Shutterstock.com. Contract development and manufacturing organisations

Wel­come back to End­points Week­ly, your re­view of the week’s top bio­phar­ma head­lines. Want this in your in­box every Sat­ur­day morn­ing? Cur­rent End­points read­ers can vis­it